Keros Therapeutics, Inc.
KROS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001664710
In the last 90 days, Keros Therapeutics, Inc. insiders filed 2 open-market purchases and 4 sales; 132 institutions reported holding it in 13F filings for Q2 2026, worth $198.6M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Keros Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 129
- +3 vs. Q4 2022
- Shares held
- 22.0M
- +2.26M (+11.4%) vs. Q4 2022
- Total value
- $937.0M
- −$11.2M (−1.2%) vs. Q4 2022
- New holders
- 20
- 50 more added
- Sold out
- 17
- 33 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KROS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 132 | $198.6M |
| Q1 2026 | 151 | $205.6M |
| Q4 2025 | 166 | $408.4M |
| Q3 2025 | 155 | $558.0M |
| Q2 2025 | 139 | $479.6M |
| Q1 2025 | 156 | $428.6M |
| Q4 2024 | 161 | $582.1M |
| Q3 2024 | 164 | $2.03B |
| Q2 2024 | 152 | $1.44B |
| Q1 2024 | 147 | $2.08B |
| Q4 2023 | 121 | $1.02B |
| Q3 2023 | 107 | $730.6M |
| Q2 2023 | 123 | $901.0M |
| Q1 2023 | 129 | $937.0M |
| Q4 2022 | 126 | $948.2M |
| Q3 2022 | 113 | $680.1M |
| Q2 2022 | 104 | $479.7M |
| Q1 2022 | 106 | $893.0M |
| Q4 2021 | 99 | $944.5M |
| Q3 2021 | 89 | $545.4M |
| Q2 2021 | 80 | $599.7M |
| Q1 2021 | 83 | $887.0M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Keros Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 121,100 | $5.17M | 0.01% | +29,200+31.8% | Added |
| Soleus Capital Management, L.P. | 122,316 | $5.22M | 0.65% | −110,800−47.5% | Reduced |
| Bank of New York Mellon Corp | 132,577 | $5.66M | 0.00% | +38,650+41.1% | Added |
| Charles Schwab Investment Management Inc | 132,768 | $5.67M | 0.00% | −584−0.4% | Reduced |
| Morgan Stanley | 140,970 | $6.02M | 0.00% | −1,991−1.4% | Reduced |
| Northern Trust Corp | 177,270 | $7.57M | 0.00% | +2,506+1.4% | Added |
| Parkman Healthcare Partners LLC | 179,290 | $7.66M | 1.67% | +52,500+41.4% | Added |
| Woodline Partners LP | 198,139 | $8.46M | 0.12% | +1,440+0.7% | Added |
| Point72 Asset Management, L.P. | 205,660 | $8.78M | 0.03% | −314,876−60.5% | Reduced |
| Opaleye Management Inc. | 238,000 | $10.2M | 3.04% | 00.0% | Unchanged |
| CHI Advisors LLC | 261,059 | $11.1M | 2.96% | +46,000+21.4% | Added |
| Clal Insurance Enterprises Holdings Ltd | 299,000 | $12.8M | 0.19% | 00.0% | Unchanged |
| Eventide Asset Management, LLC | 300,000 | $12.8M | 0.24% | +300,000 | New |
| Citigroup Inc | 326,064 | $13.9M | 0.02% | −86,039−20.9% | Reduced |
| Geode Capital Management, LLC | 368,046 | $15.7M | 0.00% | +18,298+5.2% | Added |
| Citadel Advisors LLC | 371,483 | $15.9M | 0.02% | −33,988−8.4% | Reduced |
| Franklin Resources Inc | 472,751 | $20.2M | 0.01% | 00.0% | Unchanged |
| Yiheng Capital Management, L.P. | 554,151 | $23.7M | 1.84% | +554,151 | New |
| First Light Asset Management, LLC | 593,964 | $25.4M | 2.28% | +1,552+0.3% | Added |
| Candriam Luxembourg S.C.A. | 745,057 | $29.3M | 0.20% | +119,143+19.0% | Added |
| Nantahala Capital Management, LLC | 742,819 | $31.7M | 3.04% | −49,274−6.2% | Reduced |
| Paradigm Biocapital Advisors LP | 930,752 | $39.7M | 3.77% | +930,752 | New |
| State Street Corp | 944,159 | $40.3M | 0.00% | −23,979−2.5% | Reduced |
| Vanguard Group Inc | 1,048,062 | $44.8M | 0.00% | +2,742+0.3% | Added |
| Price T Rowe Associates Inc | 1,152,516 | $49.2M | 0.01% | +531,327+85.5% | Added |
| BlackRock Inc. | 1,677,260 | $71.6M | 0.00% | +38,934+2.4% | Added |
| Alkeon Capital Management LLC | 1,678,018 | $71.7M | 0.46% | +285,616+20.5% | Added |
| OrbiMed Advisors LLC | 1,679,417 | $71.7M | 1.42% | 00.0% | Unchanged |
| FMR LLC | 4,051,873 | $173.0M | 0.02% | +372,784+10.1% | Added |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Casdin Capital, LLC | 0 | $0 | 0.00% | −65,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −21,222−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −19,400−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −18,616−100.0% | Sold out |
| Meitav Dash Investments Ltd | 0 | $0 | 0.00% | −17,475−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −11,823−100.0% | Sold out |
| Brookfield Asset Management Inc. | 0 | $0 | 0.00% | −9,014−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −8,760−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −4,753−100.0% | Sold out |
| SVB Financial Group | 0 | $0 | 0.00% | −4,653−100.0% | Sold out |
| BIT Capital GmbH | 0 | $0 | 0.00% | −1,330−100.0% | Sold out |
| Zullo Investment Group, Inc. | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −270−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −53−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −38−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −41−100.0% | Sold out |